Neximmune inc.

Major-Pharmaceuticals

NEXI


9119 Gaither Road
Gaithersburg , MD 20877

Executive/
Director

Price

  • Last Close
  • $ 0.18
    $ -0.04 -19.46 %
    Oct 18, 2023
  • 52-Week High/Low
  • $0.26 - $0.18
  • YTD
  • 0%

  • Trading Volume
  • 1,111,828
  • Market Cap Full
  • $ 190.5K
  • Shares Outstanding
  • 1.1M
    Nov 1, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - - - -8.7% 56.4% -
Q2 - - - - - - -14.5% -61.8% -26.6% -
Q3 - - - - - - -7.2% -65.5% -28.3% -
Q4 - - - - - - -69.6% -56.2% -14.8% -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 67.5% 5.7% -11.6% -5% -11.1% -13.1% 3.9% -26.2% -6.5% -11% - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%0%-95%-27%0%

Earnings

2020 2021 2022 2023
Q1 - -0.71 -0.66 -9.25
Q2 - -0.54 -0.69 -7.25
Q3 - -0.65 -0.6 -9.40
Q4 - -0.64 -16.25 -
A -26.4 -2.5 -2.6 -25.9

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar 22.6 22.8 26.1
Jun 22.6 - 26.1
Sep 22.7 24.2 26.1
Dec 22.8 26.1 1.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - 26.5 -14 - -
Equity multiplier 0.1 0.1 - -0.1 -